A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients

A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients

Abstract Background This study was an open-label, 2-arms, monocentric, randomized clinical trial comparing Xonrid®, a topical medical device, versus standard of care (SOC) in preventing and treating acute radiation dermatitis (ARD) in Head and Neck Cancer (HNC) and Breast Cancer (BC) patients underg...

Full description

Bibliographic Details
Main Authors: Rossana Ingargiola, Maria Carmen De Santis, Nicola Alessandro Iacovelli, Nadia Facchinetti, Anna Cavallo, Eliana Ivaldi, Michela Dispinzieri, Marzia Franceschini, Carlotta Giandini, Domenico Attilio Romanello, Simona Di Biaso, Michela Sabetti, Laura Locati, Salvatore Alfieri, Paolo Bossi, Mauro Guglielmo, Fabio Macchi, Laura Lozza, Riccardo Valdagni, Carlo Fallai, Emanuele Pignoli, Ester Orlandi
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Radiation Oncology
Subjects:
Head and neck cancer
Breast cancer
Acute radiation dermatitis
Skin toxicity
Xonrid®
Skindex-16
Online Access:http://link.springer.com/article/10.1186/s13014-020-01633-0

Internet

http://link.springer.com/article/10.1186/s13014-020-01633-0

Similar Items